Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer cells, while sparing healthy cells in the body. The company was incorporated in 2016 and is headquartered in South San Francisco, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [12/30/2025 16:30 PST] Senti Biosciences, Inc. (NASDAQ:SNTI), Down By 100% ($1.2) From $1.2 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [12/23/2025 07:48 PST] SNTI Expected to Trade Up After Bullish Patterns Develop
• [12/22/2025 07:29 PST] SNTI Expected to Trade Down After Bearish Patterns Develop
• [12/15/2025 11:07 PST] Senti Biosciences, Inc. (NASDAQ:SNTI), Down By 100% ($1.41) From $1.41 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [12/12/2025 07:05 PST] SNTI Expected to Trade Down After Bearish Patterns Develop
• [12/09/2025 21:20 PST] Market Maker Surveillance Report. SNTI, Losing Stocks With Lowest Price Friction For Tuesday, December 9th 2025
• [11/24/2025 06:48 PST] SNTI Expected to Trade Up After Bullish Patterns Develop
• [11/07/2025 07:07 PST] SNTI Expected to Trade Up After Bullish Patterns Develop